Cargando…

Aromatization Is Not Required for the Facilitation of Appetitive Sexual Behaviors in Ovariectomized Rats Treated With Estradiol and Testosterone

Testosterone can be safely and effectively administered to estrogen-treated post-menopausal women experiencing hypoactive sexual desire. However, in the United States and Canada, although it is often administered off-label, testosterone co-administered with estradiol is not a federally approved trea...

Descripción completa

Detalles Bibliográficos
Autores principales: Jones, Sherri Lee, Rosenbaum, Stephanie, Gardner Gregory, James, Pfaus, James G.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6691068/
https://www.ncbi.nlm.nih.gov/pubmed/31447629
http://dx.doi.org/10.3389/fnins.2019.00798
_version_ 1783443289988399104
author Jones, Sherri Lee
Rosenbaum, Stephanie
Gardner Gregory, James
Pfaus, James G.
author_facet Jones, Sherri Lee
Rosenbaum, Stephanie
Gardner Gregory, James
Pfaus, James G.
author_sort Jones, Sherri Lee
collection PubMed
description Testosterone can be safely and effectively administered to estrogen-treated post-menopausal women experiencing hypoactive sexual desire. However, in the United States and Canada, although it is often administered off-label, testosterone co-administered with estradiol is not a federally approved treatment for sexual arousal/desire disorder, partly because its mechanism is poorly understood. One possible mechanism involves the aromatization of testosterone to estradiol. In an animal model, the administration of testosterone propionate (TP) given in combination with estradiol benzoate (EB) significantly increases sexually appetitive behaviors (i.e., solicitations and hops/darts) in ovariectomized (OVX) Long-Evans rats, compared to those treated with EB-alone. The goal of current study was to test whether blocking aromatization of testosterone to estradiol would disrupt the facilitation of sexual behaviors in OVX Long-Evans rats, and to determine group differences in Fos immunoreactivity within brain regions involved in sexual motivation and reward. Groups of sexually experienced OVX Long-Evans rats were treated with EB alone, EB+TP, or EB+TP and the aromatase inhibitor Fadrozole (EB+TP+FAD). Females treated with EB+TP+FAD displayed significantly more hops and darts, solicitations and lordosis magnitudes when compared to EB-alone females. Furthermore, TP, administered with or without FAD, induced the activation of Fos-immunoreactivity in brain areas implicated in sexual motivation and reward including the medial preoptic area, ventrolateral division of the ventromedial nucleus of the hypothalamus, the nucleus accumbens core, and the prefrontal cortex. These results suggest that aromatization may not be necessary for TP to enhance female sexual behavior and that EB+TP may act via androgenic pathways to increase the sensitivity of response to male-related cues, to induce female sexual desire.
format Online
Article
Text
id pubmed-6691068
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-66910682019-08-23 Aromatization Is Not Required for the Facilitation of Appetitive Sexual Behaviors in Ovariectomized Rats Treated With Estradiol and Testosterone Jones, Sherri Lee Rosenbaum, Stephanie Gardner Gregory, James Pfaus, James G. Front Neurosci Neuroscience Testosterone can be safely and effectively administered to estrogen-treated post-menopausal women experiencing hypoactive sexual desire. However, in the United States and Canada, although it is often administered off-label, testosterone co-administered with estradiol is not a federally approved treatment for sexual arousal/desire disorder, partly because its mechanism is poorly understood. One possible mechanism involves the aromatization of testosterone to estradiol. In an animal model, the administration of testosterone propionate (TP) given in combination with estradiol benzoate (EB) significantly increases sexually appetitive behaviors (i.e., solicitations and hops/darts) in ovariectomized (OVX) Long-Evans rats, compared to those treated with EB-alone. The goal of current study was to test whether blocking aromatization of testosterone to estradiol would disrupt the facilitation of sexual behaviors in OVX Long-Evans rats, and to determine group differences in Fos immunoreactivity within brain regions involved in sexual motivation and reward. Groups of sexually experienced OVX Long-Evans rats were treated with EB alone, EB+TP, or EB+TP and the aromatase inhibitor Fadrozole (EB+TP+FAD). Females treated with EB+TP+FAD displayed significantly more hops and darts, solicitations and lordosis magnitudes when compared to EB-alone females. Furthermore, TP, administered with or without FAD, induced the activation of Fos-immunoreactivity in brain areas implicated in sexual motivation and reward including the medial preoptic area, ventrolateral division of the ventromedial nucleus of the hypothalamus, the nucleus accumbens core, and the prefrontal cortex. These results suggest that aromatization may not be necessary for TP to enhance female sexual behavior and that EB+TP may act via androgenic pathways to increase the sensitivity of response to male-related cues, to induce female sexual desire. Frontiers Media S.A. 2019-08-06 /pmc/articles/PMC6691068/ /pubmed/31447629 http://dx.doi.org/10.3389/fnins.2019.00798 Text en Copyright © 2019 Jones, Rosenbaum, Gardner Gregory and Pfaus. http://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Neuroscience
Jones, Sherri Lee
Rosenbaum, Stephanie
Gardner Gregory, James
Pfaus, James G.
Aromatization Is Not Required for the Facilitation of Appetitive Sexual Behaviors in Ovariectomized Rats Treated With Estradiol and Testosterone
title Aromatization Is Not Required for the Facilitation of Appetitive Sexual Behaviors in Ovariectomized Rats Treated With Estradiol and Testosterone
title_full Aromatization Is Not Required for the Facilitation of Appetitive Sexual Behaviors in Ovariectomized Rats Treated With Estradiol and Testosterone
title_fullStr Aromatization Is Not Required for the Facilitation of Appetitive Sexual Behaviors in Ovariectomized Rats Treated With Estradiol and Testosterone
title_full_unstemmed Aromatization Is Not Required for the Facilitation of Appetitive Sexual Behaviors in Ovariectomized Rats Treated With Estradiol and Testosterone
title_short Aromatization Is Not Required for the Facilitation of Appetitive Sexual Behaviors in Ovariectomized Rats Treated With Estradiol and Testosterone
title_sort aromatization is not required for the facilitation of appetitive sexual behaviors in ovariectomized rats treated with estradiol and testosterone
topic Neuroscience
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6691068/
https://www.ncbi.nlm.nih.gov/pubmed/31447629
http://dx.doi.org/10.3389/fnins.2019.00798
work_keys_str_mv AT jonessherrilee aromatizationisnotrequiredforthefacilitationofappetitivesexualbehaviorsinovariectomizedratstreatedwithestradiolandtestosterone
AT rosenbaumstephanie aromatizationisnotrequiredforthefacilitationofappetitivesexualbehaviorsinovariectomizedratstreatedwithestradiolandtestosterone
AT gardnergregoryjames aromatizationisnotrequiredforthefacilitationofappetitivesexualbehaviorsinovariectomizedratstreatedwithestradiolandtestosterone
AT pfausjamesg aromatizationisnotrequiredforthefacilitationofappetitivesexualbehaviorsinovariectomizedratstreatedwithestradiolandtestosterone